Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Comments

Response to comment on: "Brentuximab-vedotin and bendamustine for relapsed or refractory Hodgkin lymphoma: the LYSA real-world experience"

CHU de Bordeaux, Service d’hématologie Clinique et de thérapie cellulaire
CHU de Bordeaux, Service d’hématologie Clinique et de thérapie cellulaire
CHU de Bordeaux, Service d’hématologie Clinique et de thérapie cellulaire
Haematologica Early view Jul 9, 2026 https://doi.org/10.3324/haematol.2026.301477

Abstract

Not available.

Figures & Tables

Article Information

Early view : Comments
 
DOI
https://doi.org/10.3324/haematol.2026.301477
 
Published
2026-07-09
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2026 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

No Data Yet
No Data
PlumX
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online